Roundtable Discussion: Addressing Safety Concerns in Fc-Targeted Therapies for Improved Patient Safety to Enhance Clinical Confidence
Time: 1:30 pm
day: Conference Day Two
Details:
• Investigating potential off-target effects and cytokine release syndromes to identify and mitigate potential safety risks to develop well-tolerated and safe Fc-based therapies
• Implementing robust preclinical safety studies and clinical monitoring strategies to proactively address safety concerns to build clinical confidence in the use of Fc-targeted therapies
• Analysing real-world safety data and patient-reported outcomes to understand the long-term safety profile of Fc-based therapies to provide evidence-based guidance for patient management and treatment decisions
